Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors

Background Limited data exist for management strategies targeting immunotherapy-related enteritis (irEnteritis). Systemic corticosteroids are commonly used but often are limited by adverse events. Enteric corticosteroids such as budesonide offer an attractive alternative; however, the ileocolonic re...

Full description

Saved in:
Bibliographic Details
Main Authors: Amitabh Srivastava, Michael Postow, David Faleck, Patrick Tiongco Magahis, Tara Corso, Pamela Livingstone, Erika Tom
Format: Article
Language:English
Published: BMJ Publishing Group 2024-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/12/7/e009051.full
Tags: Add Tag
No Tags, Be the first to tag this record!